Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR3A | P46098 | 5/20 | 0.33 |
| ▸ | HTR4 | Q13639 | 5/20 | 0.33 |
| ▸ | HCN1 | O60741 | 1/20 | 0.31 |
| ▸ | HCN4 | Q9Y3Q4 | 1/20 | 0.31 |
| ▸ | ADRA1D | P25100 | 1/20 | 0.31 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.31 |
| ▸ | ADRA1B | P35368 | 1/20 | 0.31 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.31 |
| ▸ | ABCG2 | Q9UNQ0 | 1/20 | 0.31 |
| ▸ | MAP3K7 | O43318 | 1/20 | 0.30 |
| ▸ | EGFR | P00533 | 1/20 | 0.30 |
| ▸ | KDR | P35968 | 1/20 | 0.30 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL7971852 | 0.99 | HTR3A (0.33) | HTR3AHTR4HCN1HCN4ADRA1D | |
| SCHEMBL7480852 | 0.94 | ADRA1D (0.32) | HCN1HCN4ADRA1DADRA1AADRA1B | |
| Hydrochloric Acid SCHEMBL7481456 | 0.94 | ADRA1D (0.32) | HCN1HCN4ADRA1DADRA1AADRA1B | |
| SCHEMBL7964767 | 0.93 | ADRA1D (0.32) | HCN1HCN4ADRA1DADRA1AADRA1B | |
| SCHEMBL7478323 | 0.92 | MAP3K7 (0.31) | HCN1HCN4ADRA1DADRA1AADRA1B | |
| SCHEMBL7600003 | 0.89 | ABL1 (0.33) | ADRA1DADRA1AADRA1BABCB1ABCG2 | |
| SCHEMBL7975460 | 0.88 | MAP3K7 (0.34) | HCN1HCN4ADRA1DADRA1AADRA1B | |
| SCHEMBL7963895 | 0.88 | HTR3A (0.36) | HTR3AHTR4MAP3K7 | |
| Hydrochloric Acid SCHEMBL7971849 | 0.87 | HTR3A (0.35) | HTR3AHTR4MAP3K7 | |
| SCHEMBL7963902 | 0.86 | HTR3A (0.35) | HTR3AHTR4ADRA1DADRA1AADRA1B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6316482-B1 | FOR THERAPY AND PROPHYLAXIS OF HYPERTENSION, HEART FAILURE, RENAL INSUFFICIENCY, EDEMA, ASCITES, VASOPRESSIN PARASECRETION SYNDROME, HEPATOCIRRHOSIS, HYPONATREMIA, HYPOKALEMIA, DIABETIC, CIRCULATION DISORDER, CEREBROVASCULAR DISEASE | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2001-11-13 | — | — | US | disclosed |
| EP-0946519-A1 | BENZAMIDE DERIVATIVES HAVING A VASOPRESSIN ANTAGONISTIC ACTIVITY | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1999-10-06 | — | — | EP | disclosed |
| WO-1998024771-A1 | BENZAMIDE DERIVATIVES HAVING A VASOPRESSIN ANTAGONISTIC ACTIVITY | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1998-06-11 | — | — | WO | disclosed |